MedPath

CardioGen-82

These highlights do not include all the information needed to use CARDIOGEN-82 safely and effectively. See full prescribing information for CARDIOGEN-82. CARDIOGEN-82 (rubidium Rb 82 generator)To produce rubidium Rb 82 chloride injection, for intravenous useInitial U.S. Approval: 1989

Approved
Approval ID

ee95aa18-9f2f-40eb-9b4c-583bea6f36bf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 26, 2022

Manufacturers
FDA

Bracco Diagnostics Inc

DUNS: 849234661

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Rubidium Chloride RB-82

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0270-0091
Application NumberNDA019414
Product Classification
M
Marketing Category
C73594
G
Generic Name
Rubidium Chloride RB-82
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 2, 2021
FDA Product Classification

INGREDIENTS (1)

RUBIDIUM CHLORIDE RB-82Active
Quantity: 150 mCi in 1 1
Code: F0Z746KRKQ
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CardioGen-82 - FDA Drug Approval Details